Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.

Flores EM, Woeller CF, Falsetta ML, Susiarjo M, Phipps RP.

FASEB J. 2019 Mar;33(3):3353-3363. doi: 10.1096/fj.201801481R. Epub 2018 Oct 30.

PMID:
30376360
2.

Key roles for lipid mediators in the adaptive immune response.

Duffney PF, Falsetta ML, Rackow AR, Thatcher TH, Phipps RP, Sime PJ.

J Clin Invest. 2018 Jul 2;128(7):2724-2731. doi: 10.1172/JCI97951. Epub 2018 Jul 2. Review.

3.

Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.

Falsetta ML, Foster DC, Woeller CF, Pollock SJ, Bonham AD, Piekna-Przybylska D, Maggirwar SB, Haidaris CG, Phipps RP.

J Low Genit Tract Dis. 2018 Jan;22(1):52-57. doi: 10.1097/LGT.0000000000000364.

4.

A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Falsetta ML, Foster DC, Woeller CF, Pollock SJ, Bonham AD, Haidaris CG, Phipps RP.

J Pain. 2016 Nov;17(11):1183-1197. doi: 10.1016/j.jpain.2016.07.007. Epub 2016 Aug 18.

5.

A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Falsetta ML, Foster DC, Bonham AD, Phipps RP.

BJOG. 2017 Jan;124(2):210-218. doi: 10.1111/1471-0528.14157. Epub 2016 Jun 17. Review.

6.

Identification of novel mechanisms involved in generating localized vulvodynia pain.

Falsetta ML, Foster DC, Woeller CF, Pollock SJ, Bonham AD, Haidaris CG, Stodgell CJ, Phipps RP.

Am J Obstet Gynecol. 2015 Jul;213(1):38.e1-38.e12. doi: 10.1016/j.ajog.2015.02.002. Epub 2015 Feb 12.

7.

Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women.

Foster DC, Falsetta ML, Woeller CF, Pollock SJ, Song K, Bonham A, Haidaris CG, Stodgell CJ, Messing SP, Iadarola M, Phipps RP.

Pain. 2015 Mar;156(3):386-96. doi: 10.1097/01.j.pain.0000460320.95267.5d.

8.

α-Mangostin disrupts the development of Streptococcus mutans biofilms and facilitates its mechanical removal.

Nguyen PT, Falsetta ML, Hwang G, Gonzalez-Begne M, Koo H.

PLoS One. 2014 Oct 28;9(10):e111312. doi: 10.1371/journal.pone.0111312. eCollection 2014.

9.

Quantification of confocal images of biofilms grown on irregular surfaces.

Sommerfeld Ross S, Tu MH, Falsetta ML, Ketterer MR, Kiedrowski MR, Horswill AR, Apicella MA, Reinhardt JM, Fiegel J.

J Microbiol Methods. 2014 May;100:111-20. doi: 10.1016/j.mimet.2014.02.020. Epub 2014 Mar 13.

10.

Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo.

Falsetta ML, Klein MI, Colonne PM, Scott-Anne K, Gregoire S, Pai CH, Gonzalez-Begne M, Watson G, Krysan DJ, Bowen WH, Koo H.

Infect Immun. 2014 May;82(5):1968-81. doi: 10.1128/IAI.00087-14. Epub 2014 Feb 24.

11.

Effect of neovestitol-vestitol containing Brazilian red propolis on accumulation of biofilm in vitro and development of dental caries in vivo.

Bueno-Silva B, Koo H, Falsetta ML, Alencar SM, Ikegaki M, Rosalen PL.

Biofouling. 2013;29(10):1233-42. doi: 10.1080/08927014.2013.834050. Epub 2013 Oct 7.

12.

The exopolysaccharide matrix: a virulence determinant of cariogenic biofilm.

Koo H, Falsetta ML, Klein MI.

J Dent Res. 2013 Dec;92(12):1065-73. doi: 10.1177/0022034513504218. Epub 2013 Sep 17. Review.

13.

Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo.

Falsetta ML, Klein MI, Lemos JA, Silva BB, Agidi S, Scott-Anne KK, Koo H.

Antimicrob Agents Chemother. 2012 Dec;56(12):6201-11. doi: 10.1128/AAC.01381-12. Epub 2012 Sep 17.

14.

Proteomic analysis of Neisseria gonorrhoeae biofilms shows shift to anaerobic respiration and changes in nutrient transport and outermembrane proteins.

Phillips NJ, Steichen CT, Schilling B, Post DM, Niles RK, Bair TB, Falsetta ML, Apicella MA, Gibson BW.

PLoS One. 2012;7(6):e38303. doi: 10.1371/journal.pone.0038303. Epub 2012 Jun 6.

15.

The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm.

Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR 3rd, Heydorn A, Koo H.

PLoS Pathog. 2012;8(4):e1002623. doi: 10.1371/journal.ppat.1002623. Epub 2012 Apr 5.

16.

Phenotypic characterization of a copA mutant of Neisseria gonorrhoeae identifies a link between copper and nitrosative stress.

Djoko KY, Franiek JA, Edwards JL, Falsetta ML, Kidd SP, Potter AJ, Chen NH, Apicella MA, Jennings MP, McEwan AG.

Infect Immun. 2012 Mar;80(3):1065-71. doi: 10.1128/IAI.06163-11. Epub 2011 Dec 19.

17.

The Composition and Metabolic Phenotype of Neisseria gonorrhoeae Biofilms.

Falsetta ML, Steichen CT, McEwan AG, Cho C, Ketterer M, Shao J, Hunt J, Jennings MP, Apicella MA.

Front Microbiol. 2011 Apr 18;2:75. doi: 10.3389/fmicb.2011.00075. eCollection 2011.

18.

Natural products in caries research: current (limited) knowledge, challenges and future perspective.

Jeon JG, Rosalen PL, Falsetta ML, Koo H.

Caries Res. 2011;45(3):243-63. doi: 10.1159/000327250. Epub 2011 May 12. Review.

19.

Influences of trans-trans farnesol, a membrane-targeting sesquiterpenoid, on Streptococcus mutans physiology and survival within mixed-species oral biofilms.

Jeon JG, Pandit S, Xiao J, Gregoire S, Falsetta ML, Klein MI, Koo H.

Int J Oral Sci. 2011 Apr;3(2):98-106. doi: 10.4248/IJOS11038.

20.

Anaerobic metabolism occurs in the substratum of gonococcal biofilms and may be sustained in part by nitric oxide.

Falsetta ML, McEwan AG, Jennings MP, Apicella MA.

Infect Immun. 2010 May;78(5):2320-8. doi: 10.1128/IAI.01312-09. Epub 2010 Mar 15.

21.

Transcriptional profiling identifies the metabolic phenotype of gonococcal biofilms.

Falsetta ML, Bair TB, Ku SC, Vanden Hoven RN, Steichen CT, McEwan AG, Jennings MP, Apicella MA.

Infect Immun. 2009 Sep;77(9):3522-32. doi: 10.1128/IAI.00036-09. Epub 2009 Jun 15.

22.

Esterase D is essential for protection of Neisseria gonorrhoeae against nitrosative stress and for bacterial growth during interaction with cervical epithelial cells.

Potter AJ, Kidd SP, Edwards JL, Falsetta ML, Apicella MA, Jennings MP, McEwan AG.

J Infect Dis. 2009 Jul 15;200(2):273-8. doi: 10.1086/599987.

23.

Phasevarions mediate random switching of gene expression in pathogenic Neisseria.

Srikhanta YN, Dowideit SJ, Edwards JL, Falsetta ML, Wu HJ, Harrison OB, Fox KL, Seib KL, Maguire TL, Wang AH, Maiden MC, Grimmond SM, Apicella MA, Jennings MP.

PLoS Pathog. 2009 Apr;5(4):e1000400. doi: 10.1371/journal.ppat.1000400. Epub 2009 Apr 24.

24.

Thioredoxin reductase is essential for protection of Neisseria gonorrhoeae against killing by nitric oxide and for bacterial growth during interaction with cervical epithelial cells.

Potter AJ, Kidd SP, Edwards JL, Falsetta ML, Apicella MA, Jennings MP, McEwan AG.

J Infect Dis. 2009 Jan 15;199(2):227-35. doi: 10.1086/595737.

25.

Metal binding specificity of the MntABC permease of Neisseria gonorrhoeae and its influence on bacterial growth and interaction with cervical epithelial cells.

Lim KH, Jones CE, vanden Hoven RN, Edwards JL, Falsetta ML, Apicella MA, Jennings MP, McEwan AG.

Infect Immun. 2008 Aug;76(8):3569-76. doi: 10.1128/IAI.01725-07. Epub 2008 Apr 21.

26.

Characterization of the OxyR regulon of Neisseria gonorrhoeae.

Seib KL, Wu HJ, Srikhanta YN, Edwards JL, Falsetta ML, Hamilton AJ, Maguire TL, Grimmond SM, Apicella MA, McEwan AG, Jennings MP.

Mol Microbiol. 2007 Jan;63(1):54-68. Epub 2006 Nov 27.

Supplemental Content

Loading ...
Support Center